User profiles for William D. Foulkes

William D. Foulkes

Professor of Oncology, Medicine, and Human Genetics. McGill University
Verified email at mail.mcgill.ca
Cited by 69585

Triple-negative breast cancer

WD Foulkes, IE Smith… - New England journal of …, 2010 - Mass Medical Soc
… The absence of both estrogen receptors (Panel D, upper portion, with normal lobules and
ducts containing estrogen-receptor–positive cells present in the bottom right corner; …

[PDF][PDF] REVEL: an ensemble method for predicting the pathogenicity of rare missense variants

…, WJ Catalona, WD Foulkes, D Mandal… - The American Journal of …, 2016 - cell.com
The vast majority of coding variants are rare, and assessment of the contribution of rare
variants to complex traits is hampered by low statistical power and limited functional data. …

[HTML][HTML] Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis …

…, H Nevanlinna, LA Akslen, LR Bégin, WD Foulkes… - PLoS …, 2010 - journals.plos.org
Background Immunohistochemical markers are often used to classify breast cancer into
subtypes that are biologically distinct and behave differently. The aim of this study was to …

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

WD Foulkes, IM Stefansson… - Journal of the …, 2003 - academic.oup.com
A basal epithelial phenotype is found in not more than 15% of all invasive breast cancers.
Microarray studies have shown that this phenotype is associated with breast cancers that …

BRCA1 and BRCA2: 1994 and beyond

SA Narod, WD Foulkes - Nature Reviews Cancer, 2004 - nature.com
The discovery of the first gene associated with hereditary breast cancer, BRCA1, was
anticipated to greatly increase our understanding of both hereditary and sporadic forms of breast …

[HTML][HTML] Breast-Cancer Risk in Families with Mutations in PALB2

…, MC Southey, R Winqvist, WD Foulkes… - … England Journal of …, 2014 - Mass Medical Soc
Background Germline loss-of-function mutations in PALB2 are known to confer a predisposition
to breast cancer. However, the lifetime risk of breast cancer that is conferred by such …

[HTML][HTML] Gene-panel sequencing and the prediction of breast-cancer risk

…, M Robson, SM Domchek, WD Foulkes - … England Journal of …, 2015 - Mass Medical Soc
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

SE Plon, DM Eccles, D Easton, WD Foulkes… - Human …, 2008 - Wiley Online Library
Genetic testing of cancer susceptibility genes is now widely applied in clinical practice to
predict risk of developing cancer. In general, sequence‐based testing of germline DNA is used …

Familial adenomatous polyposis

P Galiatsatos, WD Foulkes - … journal of the American College of …, 2006 - journals.lww.com
… Reprint requests and correspondence: William D. Foulkes, MB, Ph.… Foulkes WD. A tale
of four syndromes: Familial adenomatous polyposis, Gardner syndrome, attenuated APC and …

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation

…, J Murphy, P Ghadirian, E Friedman, WD Foulkes… - Jama, 2006 - jamanetwork.com
ContextWomen with BRCA1 or BRCA2 mutation are often advised to undergo preventive
oophorectomy. The effectiveness of this intervention has not been prospectively evaluated in a …